Atlas Trials

First in Human Safety Study of FX-345 in Adults With Sensorineural Hearing Loss

Clinical trial NCT05664100 · TERMINATED

Trial details

NCT number
NCT05664100
Sponsor
Frequency Therapeutics
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Hearing Loss, Sensorineural
Start date
2022-12-15
Primary completion
2023-04-12
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.